Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1964 2
1968 1
1970 2
1974 1
1975 2
1978 1
1979 1
1982 1
1991 1
1992 2
1997 1
1998 1
2002 2
2003 2
2004 2
2005 2
2006 5
2007 3
2008 3
2009 2
2010 2
2011 8
2012 6
2013 5
2014 11
2015 11
2016 13
2017 12
2018 13
2019 14
2020 25
2021 24
2022 29
2023 24
2024 27
2025 19

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

241 results

Results by year

Filters applied: . Clear all
Page 1
Tarlatamab in Small-Cell Lung Cancer after Platinum-Based Chemotherapy.
Mountzios G, Sun L, Cho BC, Demirci U, Baka S, Gümüş M, Lugini A, Zhu B, Yu Y, Korantzis I, Han JY, Ciuleanu TE, Ahn MJ, Rocha P, Mazières J, Lau SCM, Schuler M, Blackhall F, Yoshida T, Owonikoko TK, Paz-Ares L, Jiang T, Hamidi A, Gauto D, Recondo G, Rudin CM; DeLLphi-304 Investigators. Mountzios G, et al. Among authors: hamidi a. N Engl J Med. 2025 Jul 24;393(4):349-361. doi: 10.1056/NEJMoa2502099. Epub 2025 Jun 2. N Engl J Med. 2025. PMID: 40454646 Clinical Trial.
Practical management of adverse events in patients receiving tarlatamab, a delta-like ligand 3-targeted bispecific T-cell engager immunotherapy, for previously treated small cell lung cancer.
Sands JM, Champiat S, Hummel HD, Paulson KG, Borghaei H, Alvarez JB, Carbone DP, Carlisle JW, Choudhury NJ, Clarke JM, Gadgeel SM, Izumi H, Navarro A, Lau SCM, Lammers PE, Huang S, Hamidi A, Mukherjee S, Owonikoko TK. Sands JM, et al. Among authors: hamidi a. Cancer. 2025 Feb 1;131(3):e35738. doi: 10.1002/cncr.35738. Cancer. 2025. PMID: 39876075 Free PMC article. Review.
Single agent subcutaneous blinatumomab for advanced acute lymphoblastic leukemia.
Jabbour E, Zugmaier G, Agrawal V, Martínez-Sánchez P, Rifón Roca JJ, Cassaday RD, Böll B, Rijneveld A, Abdul-Hay M, Huguet F, Cluzeau T, Díaz MT, Vucinic V, González-Campos J, Rambaldi A, Schwartz S, Berthon C, Hernández-Rivas JM, Gordon PR, Brüggemann M, Hamidi A, Chen Y, Wong HL, Panwar B, Katlinskaya Y, Markovic A, Kantarjian H. Jabbour E, et al. Among authors: hamidi a. Am J Hematol. 2024 Apr;99(4):586-595. doi: 10.1002/ajh.27227. Epub 2024 Feb 5. Am J Hematol. 2024. PMID: 38317420 Free article.
MicroRNA-217: a therapeutic and diagnostic tumor marker.
Hamidi AA, Zangoue M, Kashani D, Zangouei AS, Rahimi HR, Abbaszadegan MR, Moghbeli M. Hamidi AA, et al. Expert Rev Mol Diagn. 2022 Jan;22(1):61-76. doi: 10.1080/14737159.2022.2017284. Epub 2021 Dec 23. Expert Rev Mol Diagn. 2022. PMID: 34883033 Review.
iSuRe-HadCre is an essential tool for effective conditional genetics.
Garcia-Gonzalez I, Rocha SF, Hamidi A, Garcia-Ortega L, Regano A, Sanchez-Muñoz MS, Lytvyn M, Garcia-Cabero A, Roig-Soucase S, Schoofs H, Castro M, Sabata H, Potente M, Graupera M, Makinen T, Benedito R. Garcia-Gonzalez I, et al. Among authors: hamidi a. Nucleic Acids Res. 2024 Jul 22;52(13):e56. doi: 10.1093/nar/gkae472. Nucleic Acids Res. 2024. PMID: 38850155 Free PMC article.
Platelets, NETs and cancer.
Cedervall J, Hamidi A, Olsson AK. Cedervall J, et al. Among authors: hamidi a. Thromb Res. 2018 Apr;164 Suppl 1:S148-S152. doi: 10.1016/j.thromres.2018.01.049. Thromb Res. 2018. PMID: 29703474 Review.
241 results